September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Reduction in the Bacterial Load on the Skin in a Clinical Setting
Author Affiliations & Notes
  • David W Stroman
    Novabay Pharmaceuticals, Inc, Irving, Texas, United States
  • Keri Mintun
    Novabay Pharmaceuticals, Inc, Irving, Texas, United States
  • Arthur B Epstein
    Ophthalmic Research Consultant of Arizona, Phoenix, Arizona, United States
  • Crystal Brimer
    Crystal Vision Services, Wilmington , North Carolina, United States
  • Chirag Patel
    Turner Eye Institute, San Leandro, California, United States
  • James Branch
    JD Branch, Winston Salem, North Carolina, United States
  • Kathryn K Najafi
    Novabay Pharmaceuticals, Inc, Irving, Texas, United States
  • Footnotes
    Commercial Relationships   David Stroman, Novabay Pharmaceuticals (E); Keri Mintun, NovaBay Pharmaceuticals (E); Arthur Epstein, Novabay Pharmaceuticals (C); Crystal Brimer, None; Chirag Patel, None; James Branch, Novabay Pharmaceuticals (C); Kathryn Najafi, Novabay Pharmaceuticals (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      David W Stroman, Keri Mintun, Arthur B Epstein, Crystal Brimer, Chirag Patel, James Branch, Kathryn K Najafi; Reduction in the Bacterial Load on the Skin in a Clinical Setting. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This clinical study investigated the magnitude of bacterial load reduction on the surface of the skin 20 minutes after application of saline containing 0.01% pure hypochlorous acid as the preservative (Avenova with Neutrox) to the skin below the lower eyelid.

Methods : Subjects with eyelid conditions that would typically be treated using lid wipes and warm compresses were enrolled into the open-label portion of clinical study CM 01-14. A microbiological specimen was collected by passing a cotton swab over an approximately 1 square centimeter area of the skin surface immediately before applying the eyelid cleanser and again twenty minutes later. The collected swabs were sent to IHMA Laboratories (Schaumburg, IL) for quantitative recovery of aerobic and anaerobic bacteria. All different colony morphologies were enumerated and processed to identify the actual species.

Results : Specimens were collected and processed from the skin below the lower eyelid of 71 eyes of 36 subjects. At time = 0, 194 unique bacterial strains belonging to 33 different species were identified. At time = +20 minutes, 138 unique bacterial strains belonging to 26 different species were recovered. No substantive differences in the species of Gram-positives, anaerobes, or Gram-negatives before and after test article application were evident.

The quantitative data for strains of specific species were paired (before and after application of the test article) for all skin specimens and demonstrated a 90% reduction in viable bacteria. Staphylococci comprised 61% of all strains recovered and S. epidermidis strains accounted for 60% of the staphylococcal strains. Both S. epiderimidis and all staphylococci were reduced by >90%. In addition, anaerobic bacteria, all Gram-positive strains and all Gram-negative strains were reduced by >90%.

Conclusions : The application of saline containing pure hypochlorous acid did not alter the diversity of bacteria recovered from the surface in any significant way. However, it did reduce the viable bacterial load and thus potentially clinically significant bacterial overpopulation by >90%.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×